In episode 5 of season 9, we’re highlighting the study, “Cost savings of reducing opioid prescribing for the treatment of people with low back pain in general practice: a modelling study”, with Dr. Anagha Killedar. You’ll hear her share a little on modeling studies and how they are conducted, considerations with different countries and healthcare systems, the actual cost and life savings estimated with reduction in opioid prescribing, those individuals who might most be interested in this paper whom we might share it with, the clinical implications and big takeaways.
Season 7, Episode 1 with Christina Abdel Shaheed: Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain
In episode 1 of season 7 of Inside the Science, we’re highlighting the study, “Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain” with Dr. Christina Abdel Shaheed. She shares some of what prompted this study, how patterns of prescribing opioids vary across the globe, some specifics on the studies included in this review, and how she would advise the reader who cares for patients with low back pain who are prescribed opioids might use this paper to advocate for their patient, the clinical implications and the big takeaways.
Season 6, Episode 15 with Christina Abdel Shaheed: Efficacy, safety, and dose-dependence of the analgesic effects of opioid therapy for people with osteoarthritis
In episode 15 of season 6 of Inside the Science, we’re highlighting the study, “Efficacy, safety, and dose-dependence of the analgesic effects of opioid therapy for people with osteoarthritis: systematic review and meta-analysis” with Dr. Christina Abdel Shaheed. She shares some of what prompted this study, the dilemma related to the use of opioids for patients with osteoarthritis, the results of the placebo-controlled studies which were included in this systematic review, the responsibility she feels clinicians have in informing the public of these results, the clinical implications and the big takeaways.